Catherine Leiendecker‐Foster

2.3k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Catherine Leiendecker‐Foster is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Catherine Leiendecker‐Foster has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Genetics and 11 papers in Rheumatology. Recurrent topics in Catherine Leiendecker‐Foster's work include Iron Metabolism and Disorders (20 papers), Hemoglobinopathies and Related Disorders (17 papers) and Folate and B Vitamins Research (11 papers). Catherine Leiendecker‐Foster is often cited by papers focused on Iron Metabolism and Disorders (20 papers), Hemoglobinopathies and Related Disorders (17 papers) and Folate and B Vitamins Research (11 papers). Catherine Leiendecker‐Foster collaborates with scholars based in United States, Canada and Netherlands. Catherine Leiendecker‐Foster's co-authors include John H. Eckfeldt, Paul C. Adams, Ronald T. Acton, Gordon D. McLaren, James C. Barton, Victor R. Gordeuk, David M. Reboussin, Fitzroy W. Dawkins, Christine E. McLaren and Mark Speechley and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Catherine Leiendecker‐Foster

32 papers receiving 1.4k citations

Hit Papers

Hemochromatosis and Iron-Overload Screening in a Racially... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
    2005 547 citations Paul C. Adams, David M. Reboussin et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Leiendecker‐Foster United States 17 919 746 574 232 165 32 1.5k
Ahmad Hanif United States 7 815 0.9× 512 0.7× 440 0.8× 67 0.3× 74 0.4× 10 1.2k
Jerome L. Sullivan United States 15 455 0.5× 272 0.4× 241 0.4× 87 0.4× 84 0.5× 28 937
P. Hopmeier Austria 16 375 0.4× 295 0.4× 156 0.3× 42 0.2× 64 0.4× 41 852
Andreas Stadlmayr Austria 17 164 0.2× 100 0.1× 230 0.4× 72 0.3× 688 4.2× 31 1.2k
Barbara Lunghi Italy 21 1.2k 1.3× 465 0.6× 42 0.1× 46 0.2× 44 0.3× 67 1.9k
Helen Ireland United Kingdom 20 500 0.5× 140 0.2× 33 0.1× 75 0.3× 99 0.6× 30 1.1k
John‐John B. Schnog Netherlands 24 757 0.8× 1.0k 1.4× 43 0.1× 114 0.5× 25 0.2× 50 1.4k
Olga Panes Chile 17 413 0.4× 68 0.1× 56 0.1× 140 0.6× 82 0.5× 28 1.1k
Emilio Rocchi Italy 17 264 0.3× 160 0.2× 263 0.5× 129 0.6× 174 1.1× 45 946
Valentina Lotto Italy 8 139 0.2× 84 0.1× 90 0.2× 176 0.8× 75 0.5× 8 544

Countries citing papers authored by Catherine Leiendecker‐Foster

Since Specialization
Citations

This map shows the geographic impact of Catherine Leiendecker‐Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Leiendecker‐Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Leiendecker‐Foster more than expected).

Fields of papers citing papers by Catherine Leiendecker‐Foster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Leiendecker‐Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Leiendecker‐Foster. The network helps show where Catherine Leiendecker‐Foster may publish in the future.

Co-authorship network of co-authors of Catherine Leiendecker‐Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Leiendecker‐Foster. A scholar is included among the top collaborators of Catherine Leiendecker‐Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Leiendecker‐Foster. Catherine Leiendecker‐Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honig, Lawrence S., Min Suk Kang, Rong Cheng, et al.. (2015). Heritability of telomere length in a study of long-lived families. Neurobiology of Aging. 36(10). 2785–2790. 60 indexed citations
2.
Huxley, Rachel, Faye L. Lopez, Richard F. MacLehose, et al.. (2013). Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study. PLoS ONE. 8(3). e59052–e59052. 39 indexed citations
3.
Lynch, Amy I., John H. Eckfeldt, Barry R. Davis, et al.. (2012). Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment. Pharmacogenetics and Genomics. 22(5). 355–366. 14 indexed citations
4.
McLaren, Christine E., Stela McLachlan, Chad Garner, et al.. (2012). Associations between Single Nucleotide Polymorphisms in Iron-Related Genes and Iron Status in Multiethnic Populations. PLoS ONE. 7(6). e38339–e38339. 43 indexed citations
5.
Zhang, Xue, Amy I. Lynch, Barry R. Davis, et al.. (2012). Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study. PLoS ONE. 7(3). e34217–e34217. 34 indexed citations
6.
McLaren, Christine E., Stela McLachlan, Chad Garner, et al.. (2011). Associations Between Single Nucleotide Polymorphisms in Iron-Related Genes and Iron Status in Multiethnic Populations. Blood. 118(21). 2105–2105. 3 indexed citations
7.
McLaren, Christine E., Chad Garner, Clare C. Constantine, et al.. (2011). Genome-Wide Association Study Identifies Genetic Loci Associated with Iron Deficiency. PLoS ONE. 6(3). e17390–e17390. 53 indexed citations
8.
Acton, Ronald T., et al.. (2010). Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Molecules and Diseases. 44(4). 252–256. 4 indexed citations
9.
Lynch, Amy I., Eric Boerwinkle, Barry R. Davis, et al.. (2009). Antihypertensive pharmacogenetic effect of fibrinogen-beta variant −455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study. Pharmacogenetics and Genomics. 19(6). 415–421. 16 indexed citations
10.
Zee, Anke H. Maitland‐van der, Bas Peters, Amy I. Lynch, et al.. (2009). The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study. Pharmacogenetics and Genomics. 19(5). 338–344. 14 indexed citations
11.
Lynch, Amy I., Eric Boerwinkle, Barry R. Davis, et al.. (2008). Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension. JAMA. 299(3). 296–307. 74 indexed citations
12.
13.
Barton, James C., Ronald T. Acton, Catherine Leiendecker‐Foster, et al.. (2007). HFE C282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening. Genetic Testing. 11(3). 269–275. 6 indexed citations
14.
Adams, Paul C., David M. Reboussin, Richard D. Press, et al.. (2007). Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity. The American Journal of Medicine. 120(11). 999.e1–999.e7. 61 indexed citations
15.
Rivers, Charles, James C. Barton, Victor R. Gordeuk, et al.. (2007). Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Molecules and Diseases. 38(3). 247–252. 41 indexed citations
16.
17.
Adams, Paul C., Leah Passmore, Subrata Chakrabarti, et al.. (2006). Liver Diseases in the Hemochromatosis and Iron Overload Screening Study. Clinical Gastroenterology and Hepatology. 4(7). 918–923.e1. 43 indexed citations
18.
Anderson, Roger T., Lari Wenzel, Ann P. Walker, et al.. (2006). Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study. Genetics in Medicine. 8(11). 681–687. 13 indexed citations
19.
Adams, Paul C., David M. Reboussin, James C. Barton, et al.. (2005). Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. New England Journal of Medicine. 352(17). 1769–1778. 547 indexed citations breakdown →
20.
McLaren, Christine E., James C. Barton, Paul C. Adams, et al.. (2003). Hemochromatosis and Iron Overload Screening (HEIRS) Study Design for an Evaluation of 100,000 Primary Care-Based Adults. The American Journal of the Medical Sciences. 325(2). 53–62. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmad Hanif Breakdown of academic impact, for papers by Jerome L. Sullivan Breakdown of academic impact, for papers by P. Hopmeier Breakdown of academic impact, for papers by Andreas Stadlmayr Breakdown of academic impact, for papers by Barbara Lunghi Breakdown of academic impact, for papers by Helen Ireland Breakdown of academic impact, for papers by John‐John B. Schnog Breakdown of academic impact, for papers by Olga Panes Breakdown of academic impact, for papers by Emilio Rocchi Breakdown of academic impact, for papers by Valentina Lotto
Rankless by CCL
2026